Efficacy and safety of remimazolam for induction and maintenance of general anesthesia in day surgery: a randomized controlled non-inferiority clinical trial.

ABSTRACT:

Background

Remimazolam is a novel ultrashort-acting benzodiazepine anesthetic demonstrated to be safe and effective for painless gastroscopy and bronchoscopy. However, research on the application of remimazolam in general anesthesia for short day surgery is relatively limited. This study aimed to evaluate the efficacy and safety of remimazolam for both the induction and maintenance of general anesthesia in short day surgery.

Method

One hundred patients who underwent elective surgery were randomly divided into two groups: the Propofol group and the Remimazolam group. The primary outcomes consisted of the rates of successful anesthesia, defined by the absence of intraoperative awareness, the need for additional sedatives, and any involuntary limb movements, along with the inci

SUBMITTER: Liang KY 

PROVIDER: S-EPMC12482367 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature